You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API artemether and lumefantrine

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing artemether and lumefantrine

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Novartis Pharmaceuticals Corporation	COARTEM	artemether and lumefantrine	0078-0568	CELLULOSE, MICROCRYSTALLINE
Novartis Pharmaceuticals Corporation	COARTEM	artemether and lumefantrine	0078-0568	CROSCARMELLOSE SODIUM
Novartis Pharmaceuticals Corporation	COARTEM	artemether and lumefantrine	0078-0568	HYPROMELLOSES
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for artemether and lumefantrine

Excipient focus: CELLULOSE, MICROCRYSTALLINE

artemether and lumefantrine drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	artemether and lumefantrine	0078-0568
Central Texas Community Health Centers	artemether and lumefantrine	76413-154
>Company	>Ingredient	>NDC

artemether and lumefantrine drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSCARMELLOSE SODIUM

artemether and lumefantrine drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	artemether and lumefantrine	0078-0568
Central Texas Community Health Centers	artemether and lumefantrine	76413-154
>Company	>Ingredient	>NDC

artemether and lumefantrine drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE

artemether and lumefantrine drug variants containing HYPROMELLOSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Central Texas Community Health Centers	artemether and lumefantrine	76413-154
>Company	>Ingredient	>NDC

artemether and lumefantrine drug variants not containing HYPROMELLOSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	artemether and lumefantrine	0078-0568
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSES

artemether and lumefantrine drug variants containing HYPROMELLOSES

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	artemether and lumefantrine	0078-0568
>Company	>Ingredient	>NDC

artemether and lumefantrine drug variants not containing HYPROMELLOSES

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Central Texas Community Health Centers	artemether and lumefantrine	76413-154
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

artemether and lumefantrine drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	artemether and lumefantrine	0078-0568
Central Texas Community Health Centers	artemether and lumefantrine	76413-154
>Company	>Ingredient	>NDC

artemether and lumefantrine drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYSORBATE 80

artemether and lumefantrine drug variants containing POLYSORBATE 80

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	artemether and lumefantrine	0078-0568
Central Texas Community Health Centers	artemether and lumefantrine	76413-154
>Company	>Ingredient	>NDC

artemether and lumefantrine drug variants not containing POLYSORBATE 80

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SILICON DIOXIDE

artemether and lumefantrine drug variants containing SILICON DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	artemether and lumefantrine	0078-0568
Central Texas Community Health Centers	artemether and lumefantrine	76413-154
>Company	>Ingredient	>NDC

artemether and lumefantrine drug variants not containing SILICON DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

artemether and lumefantrine drug variants containing WATER

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	artemether and lumefantrine	0078-0568
>Company	>Ingredient	>NDC

artemether and lumefantrine drug variants not containing WATER

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Central Texas Community Health Centers	artemether and lumefantrine	76413-154
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.